Trade ABCL anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
AbCellera Biologics Inc. Common Shares (ABCL) is trading at US$11.34, down 8.52% today as of Aug 28, 13:57 EDT. The company has a market capitalisation of US$3.67B. Over the past 52 weeks, ABCL has traded between US$2.75 and US$12.58. On Syfe you can trade ABCL with $0 commission and add it to your watchlist.
| Previous close | US$12.40 |
|---|---|
| Market cap | US$3.67B |
| 52-week range | US$2.75 – US$12.58 |
| Volume | 4.22M |
| Exchange | US |
Add to Watchlist
Set Price Alert
AbCellera Biologics Inc. Common Shares
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.
Year: 2020
Stay on top of ABCL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
